HIV-1 gp41
Acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of viral and target intracellular membranes, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. Complete fusion occurs in host cell endosomes and is dynamin-dependent, however some lipid transfer might occur at the plasma membrane. The virus undergoes clathrin-dependent internalization long before endosomal fusion, thus minimizing the surface exposure of conserved viral epitopes during fusion and reducing the efficacy of inhibitors targeting these epitopes. Membranes fusion leads to delivery of the nucleocapsid into the cytoplasm.
Full Name
Envelope glycoprotein GP41
Function
Acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of viral and target intracellular membranes, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. Complete fusion occurs in host cell endosomes and is dynamin-dependent, however some lipid transfer might occur at the plasma membrane. The virus undergoes clathrin-dependent internalization long before endosomal fusion, thus minimizing the surface exposure of conserved viral epitopes during fusion and reducing the efficacy of inhibitors targeting these epitopes. Membranes fusion leads to delivery of the nucleocapsid into the cytoplasm.
Biological Process
Actin filament reorganization Source: UniProtKB-UniRule
Clathrin-dependent endocytosis of virus by host cell Source: UniProtKB
Fusion of virus membrane with host endosome membrane Source: UniProtKB-UniRule
Fusion of virus membrane with host plasma membrane Source: UniProtKB
Mitigation of host immune response by virus Source: UniProtKB-UniRule
Positive regulation of establishment of T cell polarity Source: UniProtKB-UniRule
Positive regulation of plasma membrane raft polarization Source: UniProtKB-UniRule
Positive regulation of receptor clustering Source: UniProtKB-UniRule
Viral protein processing Source: UniProtKB
Virion attachment to host cell Source: UniProtKB
Clathrin-dependent endocytosis of virus by host cell Source: UniProtKB
Fusion of virus membrane with host endosome membrane Source: UniProtKB-UniRule
Fusion of virus membrane with host plasma membrane Source: UniProtKB
Mitigation of host immune response by virus Source: UniProtKB-UniRule
Positive regulation of establishment of T cell polarity Source: UniProtKB-UniRule
Positive regulation of plasma membrane raft polarization Source: UniProtKB-UniRule
Positive regulation of receptor clustering Source: UniProtKB-UniRule
Viral protein processing Source: UniProtKB
Virion attachment to host cell Source: UniProtKB
Cellular Location
Virion membrane; Host cell membrane; Host endosome membrane. The surface protein is not anchored to the viral envelope, but associates with the extravirion surface through its binding to TM. It is probably concentrated at the site of budding and incorporated into the virions possibly by contacts between the cytoplasmic tail of Env and the N-terminus of Gag.
PTM
Highly glycosylated by host. The high number of glycan on the protein is reffered to as 'glycan shield' because it contributes to hide protein sequence from adaptive immune system.
Palmitoylation of the transmembrane protein and of Env polyprotein (prior to its proteolytic cleavage) is essential for their association with host cell membrane lipid rafts. Palmitoylation is therefore required for envelope trafficking to classical lipid rafts, but not for viral replication.
Specific enzymatic cleavages in vivo yield mature proteins. Envelope glycoproteins are synthesized as a inactive precursor that is heavily N-glycosylated and processed likely by host cell furin in the Golgi to yield the mature SU and TM proteins. The cleavage site between SU and TM requires the minimal sequence [KR]-X-[KR]-R. About 2 of the 9 disulfide bonds of gp41 are reduced by P4HB/PDI, following binding to CD4 receptor.
Palmitoylation of the transmembrane protein and of Env polyprotein (prior to its proteolytic cleavage) is essential for their association with host cell membrane lipid rafts. Palmitoylation is therefore required for envelope trafficking to classical lipid rafts, but not for viral replication.
Specific enzymatic cleavages in vivo yield mature proteins. Envelope glycoproteins are synthesized as a inactive precursor that is heavily N-glycosylated and processed likely by host cell furin in the Golgi to yield the mature SU and TM proteins. The cleavage site between SU and TM requires the minimal sequence [KR]-X-[KR]-R. About 2 of the 9 disulfide bonds of gp41 are reduced by P4HB/PDI, following binding to CD4 receptor.
View more
Anti-HIV-1 gp41 antibodies
+ Filters
Loading...
Target: HIV-1 gp41
Host: Human
Antibody Isotype: IgG1
Specificity: HIV-1
Clone: 4E10
Application*: Neut., ELISA, IP, IF
Target: HIV-1 gp41
Host: Human
Antibody Isotype: IgG1
Specificity: HIV-1
Clone: 3D6
Application*: WB
Target: HIV-1 gp41
Host: Human
Antibody Isotype: IgG1
Specificity: HIV-1
Clone: 2F5
Application*: Neut., ELISA, IP, IF
Target: HIV-1 gp41
Host: Human
Antibody Isotype: Fab
Specificity: HIV-1
Clone: CBMC-C1132
Application*: E, FN
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV-1
Clone: CB3219
Application*: E, WB
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: 33B7
Application*: E, IF, IP, WB
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV-1
Clone: CBMC-C1073
Application*: E, IF, IP
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG2a
Specificity: HIV
Clone: CBMC-C1067
Application*: E, IF, IP
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG
Specificity: HIV-1
Clone: 1D4
Application*: WB, E
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0776
Application*: IF, IP, WB
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG2a
Specificity: HIV
Clone: CBMW-H0775
Application*: E, WB
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0774
Application*: WB, E, RI, IF
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0773
Application*: E, IC, IH, IP, WB
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG
Specificity: HIV
Clone: CBMW-H0772
Application*: LF
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG
Specificity: HIV
Clone: CBMW-H0771
Application*: E
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0069
Application*: F, E, N
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0050
Application*: WB, E
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG2a
Specificity: HIV
Clone: CBMW-H0041
Application*: WB
Target: HIV-1 gp41
Host: Human
Specificity: HIV
Clone: CBMW-H0736
Application*: E
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG2a
Specificity: HIV
Clone: CBMW-H0744
Application*: IF, WB
Target: HIV-1 gp41
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0743
Application*: IF, IP, WB
More Infomation
Hot products 
-
Mouse Anti-AKR1B1 Antibody (V2-2449) (CBMAB-1001CQ)
-
Mouse Anti-dsRNA Recombinant Antibody (2) (CBMAB-D1807-YC)
-
Mouse Anti-CD46 Recombinant Antibody (CBFYC-0076) (CBMAB-C0085-FY)
-
Rabbit Anti-ENO2 Recombinant Antibody (BA0013) (CBMAB-0272CQ)
-
Mouse Anti-ADV Recombinant Antibody (V2-503423) (CBMAB-V208-1364-FY)
-
Mouse Anti-ALOX5 Recombinant Antibody (33) (CBMAB-1890CQ)
-
Mouse Anti-CEMIP Recombinant Antibody (3C12) (CBMAB-K0296-LY)
-
Mouse Anti-BRCA2 Recombinant Antibody (CBYY-1728) (CBMAB-2077-YY)
-
Mouse Anti-FOXA3 Recombinant Antibody (2A9) (CBMAB-0377-YC)
-
Mouse Anti-BCL2L1 Recombinant Antibody (H5) (CBMAB-1025CQ)
-
Mouse Anti-ATP1B1 Recombinant Antibody (E4) (CBMAB-0463-LY)
-
Rabbit Anti-ABL1 (Phosphorylated Y245) Recombinant Antibody (V2-505716) (PTM-CBMAB-0465LY)
-
Mouse Anti-ACLY Recombinant Antibody (V2-179314) (CBMAB-A0610-YC)
-
Mouse Anti-ATP1A2 Recombinant Antibody (M7-PB-E9) (CBMAB-A4013-YC)
-
Mouse Anti-C5AR1 Recombinant Antibody (R63) (CBMAB-C9553-LY)
-
Mouse Anti-GFAP Recombinant Antibody (24) (CBMAB-G2927-LY)
-
Mouse Anti-ADIPOR2 Recombinant Antibody (V2-179983) (CBMAB-A1369-YC)
-
Mouse Anti-CHRNA9 Recombinant Antibody (8E4) (CBMAB-C9161-LY)
-
Mouse Anti-CD1C Recombinant Antibody (L161) (CBMAB-C2173-CQ)
-
Mouse Anti-ADGRL2 Recombinant Antibody (V2-58519) (CBMAB-L0166-YJ)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
Online Inquiry



